in 2017 proposed that F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter CRC chemotherapeutic response (Yu et al., 2017). Here, TLR4 is linked to colorectal carcinoma.